PTC Therapeutics, Inc.
(NASDAQ : PTCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.91%58.270.0%$1734.57m
GILDGilead Sciences, Inc. -0.25%75.131.0%$1315.09m
REGNRegeneron Pharmaceuticals, Inc. 0.93%583.592.5%$970.30m
AMGNAmgen, Inc. -0.33%223.401.3%$644.23m
NVAXNovavax, Inc. 0.38%45.01102.0%$581.92m
VRTXVertex Pharmaceuticals, Inc. 0.13%277.741.9%$545.41m
BIIBBiogen, Inc. -0.01%300.461.6%$410.34m
ILMNIllumina, Inc. -1.87%366.053.5%$381.92m
SRNESorrento Therapeutics, Inc. -0.20%4.941.8%$297.10m
ALXNAlexion Pharmaceuticals, Inc. 0.90%115.452.0%$267.45m
SGENSeattle Genetics, Inc. 0.37%152.116.1%$255.44m
AAgilent Technologies, Inc. 0.80%87.381.6%$201.10m
BMRNBioMarin Pharmaceutical, Inc. -1.20%104.334.3%$177.62m
CODXCo-Diagnostics, Inc. -1.04%17.290.0%$169.10m
INCYIncyte Corp. -0.22%100.332.5%$157.15m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.